Skip to main content
Psychedelic State(s) of America
Subscribe
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Biospace

Published November 13, 2026

HHS pumps up to $25M into ibogaine, other psychotropic drugs on Veteran's Day

Read the full story at Biospace

On Thursday, the department announced a range of investments in the psychedelic compound, along with other rapid-acting psychotropic drugs for serious.

Post on X

Share this story

Share on XShare on LinkedInShare on FacebookShare on WhatsAppShare on Signal

Surfaced by 5 Google Alerts

  • Psychedelics
  • Ibogaine
  • Ketamine
  • Psychedelic press release
  • Psychedelic biotech